Market Tracker

11/20 8:23am ET

Seattle Genetics Inc (NASDAQ:SGEN)

59.79
Delayed Data
As of Nov 17
 +0.50 / +0.84%
Today’s Change
45.31
Today|||52-Week Range
73.99
+13.30%
Year-to-Date

Today’s Trading

Previous close59.29
Today’s open58.70
Day’s range58.50 - 59.86
Volume665,770
Average volume (3 months)996,015
Market cap$8.6B
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)+7.94%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+24.15%
P/E ratioNM
Price/Sales17.76
Price/Book13.41

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.65+1.36%
ALNYAlnylam Pharmaceutic...+1.13+0.89%
TSROTESARO Inc-2.10-2.39%
IONSIonis Pharmaceutical...-0.21-0.39%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$418.1M
Annual profit (last year)-$140.1M
Net profit margin-33.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts